But the day after FDA upscheduled these hydrocodone drugs, like OxyContin, the next day, inexplicably, the FDA Director allowed the sale of Zohydro, a new, extremely potent, 10 times OxyContin's strength, is to be released with no abuse-deterrent characteristics.
Rogers criticizes the FDA's decision to allow Zohydro's sale despite its potency and lack of abuse deterrents.
Share
More from Hal Rogers
It's time for the State Department to act on the UAE's twice cited noncompliance.
It was very clear, Mr. Chairman, to people on two continents that this Kentucky delegation was serious about its constituent's well being and her need to be home.
My words were not acceptable and I expressed my regret to her, first and foremost.
While you are having so much trouble operating abroad, and don't appear to be receiving the necessary support from the administration, how can we be assured that we are making a smart investment in the agency at this time?
Other voices in this conversation
